M&G plc’s Elevance Health ELV Stock Holding History

M&G plc’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$108M	Sell	278,024 -17,094	-6%	-$6.82M	0.54%	53
2026 Q2	$114M	Sell	295,118 -824	-0.3%	-$306K	0.57%	50
2026 Q1	$86.7M	Sell	295,942 -333,038	-53%	-$109M	0.45%	57
2025 Q4	$221M	Sell	628,980 -386,133	-38%	-$130M	1.13%	27
2025 Q3	$328M	Buy	1,015,113 +84,820	+9%	+$26.4M	1.74%	7
2025 Q2	$362M	Buy	930,293 +133,992	+17%	+$53.9M	1.99%	7
2025 Q1	$346M	Buy	796,301 +27,744	+4%	+$11.1M	1.66%	9
2024 Q4	$284M	Buy	768,557 +295,469	+62%	+$124M	1.75%	10
2024 Q3	$246M	Buy	473,088 +67,774	+17%	+$36.2M	0.89%	18
2024 Q2	$220M	Buy	405,314 +13,428	+3%	+$7.1M	0.87%	16
2024 Q1	$203M	Buy	+391,886	New	+$195M	0.77%	20

Other funds holding ELV

Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

M&G plc's ELV Position: Q3 2026 in Review

M&G plc reduced its Elevance Health (ELV) stake by 5.8% in Q3 2026, selling an estimated $6.82M and leaving 278,024 shares worth $108M. The position accounts for 0.54% of the portfolio, ranked #53.

M&G plc first reported a position in ELV in Q1 2024 and has held it in 11 quarters since. The position peaked at $362M in Q2 2025. 999 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

M&G plc held 278,024 shares of Elevance Health worth $108M as of Q3 2026.
M&G plc sold 17,094 Elevance Health shares in Q3 2026, an estimated $6.82M.
Elevance Health made up 0.54% of M&G plc's portfolio in Q3 2026, its #53 holding.
M&G plc first reported a position in Elevance Health in Q1 2024 and has held it in 11 quarters since.
M&G plc's Elevance Health position peaked at $362M in Q2 2025.
999 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on M&G plc's 13F filing for Q3 2026, filed 4 Nov 2026.